isabelobrien, Author at European Medical Journal - Page 54 of 66

A debate on digital transformation

In this roundtable, three thought leaders detail the barriers in the way of digital transformation and outline their vision for the future.

What lessons can pharma learn from Silicon Valley?

How can pharma transform its approach to patients by introducing digital platforms and virtual care into their spaces?

Talking to Ana Rita Ferreira

Ana Rita Ferreira, Region Europe Medical Director, Novartis, discusses cancer care, women in STEM and misinformation.

Talking to Lorena Kuri

Lorena Kuri, Director of Clinical Trial Diversity Strategy, BMS, discusses how to address underrepresentation in clinical trials.

Talking to Rodrigo Garcia

Rodrigo Garcia, Head of Patient Centricity, Recruitment and Retention, EMD Serono, discusses the importance of diverse clinical trials.

Talking to Sir Clive Woodward part 2

Sir Clive Woodward, Former England Rugby Coach, discusses the importance of teams having aligned values and the rules of teamship.

Talking to Sir Clive Woodward part 1

Sir Clive Woodward, Former England Rugby Coach, discusses the concept of ‘Lombardi Time’ and how winning teams should embrace it.

Talking to Florent Edouard

Florent Edouard, ‎Senior Vice President, Global Head of Commercial Excellence, Grünenthal Group, talks about AI in digital transformation.

To be or to belong?

Diversity and inclusion (D&I) has become a core focus for pharma, but how can it go one step further and cultivate a culture of belonging?

Brexit revisited: how has the life sciences fared?

After years of tough negotiations, the UK has left the European Union. GOLD explores how pharmaceutical innovation has been affected as the UK works to replace EU resources and make use of its new-found regulatory freedom